share_log
Reuters ·  May 8 06:09
Zentalis Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $40 From $46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment